Shivanand Kumatagi Delivered Session on ISBT 128 at KMC Manipal
Shivanand Kumatagi, Development Officer (India) at ICCBBA, shared on LinkedIn:
”Insightful session on ISBT 128 at KMC Manipal
Had the privilege of delivering a lecture to the Postgraduate students of Transfusion Medicine KMC Manipal.
The session focused on Traceability in Transfusion Medicine—its challenges and the critical role of standardized labeling.
We discussed recent reports of suspected transfusion-transmitted HIV cases in Jharkhand, highlighting the urgent need for robust traceability mechanisms.
I emphasized how ISBT 128 standard labeling can significantly enhance Traceability and help mitigate transfusion-transmitted infections across India.
I also showcased ISBT 128 -compliant labels from Indian centers that have already adopted the standard—demonstrating real-world implementation and its impact on improving safety and accountability.
A special thanks to Eoin McGrath for joining us online and contributing to an extended and enriching discussion.
Grateful to the Transfusion Medicine KMC Manipal for hosting me.
It was a truly interactive experience, and I deeply appreciated the insights shared by the esteemed faculty of one of India’s leading institutes in Transfusion Medicine.
Looking forward to more such meaningful engagements that strengthen safe transfusion practices in India.”
Stay updated with Hemostasis Today.
-
Nov 5, 2025, 06:51Petros Gatsios Explains Why Europe Must Become Self-Sufficient in Maintaining Its Plasma Supply
-
Nov 5, 2025, 04:08Omid Seidizadeh: Pleased to Announce the Establishment of EAHAD Working Group on VWD
-
Nov 5, 2025, 03:54Marilena Vrana: ''Plasma Powers Possibility'' Continues to Resonate Far Beyond an Awareness Week
-
Nov 5, 2025, 03:30Dirk Sibbing on The Importance of ISAR-REACT 5 trial and 2020 ESC Guidelines for ACS
-
Nov 5, 2025, 03:14Abrham Mulugeta Shares Insights on Tranexamic Acid: Exploring the WHO WOMAN Trial
-
Nov 4, 2025, 08:57Toluwalase Awoyemi: Digital Health Meets Maternal Heart Care
-
Nov 4, 2025, 08:53Rebecca Ahrens Nicklas Shares FDA Interactions on Interventional Genetics with The Rare Disease Community
-
Nov 4, 2025, 06:37AI Meets Cardiology Guidelines․ Our JACC Study Is Live
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:57Multiplex Apolipoprotein Panel Boosts Cardiovascular Risk Prediction and Precision Therapy
-
Nov 4, 2025, 09:10OCCUPI Trial Analysis Highlights Benefits of OCT Guidance in ACS Patients
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Nov 4, 2025, 09:17HaemophiliaIRL Series Begins․ Advances in von Willebrand Disease Treatment
-
Nov 4, 2025, 09:14Exploring Molecular Pathways of Aging in Hematopoiesis․ FEBS Workshop 2025
-
Nov 4, 2025, 08:28Fritz Roth Thanks Supporters of Science Magazine Study Linking Genes to High Cholesterol and Heart Attack Risk
-
Nov 4, 2025, 08:22Colleen Silk on Novo Nordisk Taking the 2025 Prix Galien US Award
-
Nov 4, 2025, 08:14Cristina Anton: Excited to Be Part of Women in Hematology!